JP2022532812A5 - - Google Patents
Info
- Publication number
- JP2022532812A5 JP2022532812A5 JP2021507831A JP2021507831A JP2022532812A5 JP 2022532812 A5 JP2022532812 A5 JP 2022532812A5 JP 2021507831 A JP2021507831 A JP 2021507831A JP 2021507831 A JP2021507831 A JP 2021507831A JP 2022532812 A5 JP2022532812 A5 JP 2022532812A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence identity
- amino acid
- acid sequence
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1850983 | 2018-08-16 | ||
| PCT/EP2019/071974 WO2020035577A1 (en) | 2018-08-16 | 2019-08-15 | Anti-il1rap antibody compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022532812A JP2022532812A (ja) | 2022-07-20 |
| JP2022532812A5 true JP2022532812A5 (enExample) | 2022-08-12 |
Family
ID=67667857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021507831A Pending JP2022532812A (ja) | 2018-08-16 | 2019-08-15 | 抗ｉｌ１ｒａｐ抗体組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12209131B2 (enExample) |
| EP (1) | EP3837283B1 (enExample) |
| JP (1) | JP2022532812A (enExample) |
| CN (1) | CN112638946A (enExample) |
| WO (1) | WO2020035577A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020035577A1 (en) | 2018-08-16 | 2020-02-20 | Cantargia Ab | Anti-il1rap antibody compositions |
| IL301269A (en) | 2020-09-14 | 2023-05-01 | Ichnos Sciences S A | Antibodies that bind to IL1RAP and their uses |
| EP4267625A1 (en) * | 2020-12-23 | 2023-11-01 | Cantargia AB | Anti-il1rap antibody |
| CN117062836A (zh) * | 2021-02-05 | 2023-11-14 | 勃林格殷格翰国际有限公司 | 抗il1rap抗体 |
| CA3220913A1 (en) | 2021-05-21 | 2022-11-24 | Leo Pharma A/S | Anti il-1 receptor accessory protein antibodies |
| CA3226673A1 (en) * | 2021-07-21 | 2023-01-21 | Stelexis Therapeutics, Llc | Il1rap antibodies and uses thereof |
| CN115353566B (zh) * | 2022-09-14 | 2023-05-09 | 江苏睿源生物技术有限公司 | 用于检测白细胞介素1-β的抗体组合及其应用 |
| WO2024126833A1 (en) * | 2022-12-16 | 2024-06-20 | Ichnos Sciences SA | Cd47-il1rap bispecific antibodies |
| CN116284401B (zh) * | 2023-02-20 | 2024-09-24 | 中国人民解放军军事科学院军事医学研究院 | 人源抗il-1r3抗体及其应用 |
| EP4705340A1 (en) * | 2023-05-05 | 2026-03-11 | Otsuka Pharmaceutical Co., Ltd. | Anti-il1rap antibodies |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| AU687346B2 (en) * | 1992-06-30 | 1998-02-26 | Oncologix, Inc. | A combination of anti-erbB-2 monoclonal antibodies and method of using |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US7534866B2 (en) | 2005-10-19 | 2009-05-19 | Ibc Pharmaceuticals, Inc. | Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| US7527787B2 (en) | 2005-10-19 | 2009-05-05 | Ibc Pharmaceuticals, Inc. | Multivalent immunoglobulin-based bioactive assemblies |
| US7550143B2 (en) | 2005-04-06 | 2009-06-23 | Ibc Pharmaceuticals, Inc. | Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| CA2430013C (en) | 2000-11-30 | 2011-11-22 | Medarex, Inc. | Transgenic transchromosomal rodents for making human antibodies |
| CA2604032C (en) | 2005-04-06 | 2017-08-22 | Ibc Pharmaceuticals, Inc. | Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses |
| JP2010116338A (ja) | 2008-11-12 | 2010-05-27 | Evec Inc | 同一抗原に特異的に結合する複数の抗体の混合物もしくは複数の抗原結合部位を有する抗体 |
| GB2472856B (en) | 2009-08-21 | 2012-07-11 | Cantargia Ab | IL1-RAP modulators and uses thereof |
| US9403906B2 (en) | 2011-01-19 | 2016-08-02 | Cantargia Ab | Method of treatment of a solid tumor with interleukin-1 accessory protein antibody |
| SI3536710T1 (sl) | 2011-11-16 | 2026-04-30 | Boehringer Ingelheim International Gmbh | Protitelesa proti IL-36R |
| GB201403875D0 (en) * | 2014-03-05 | 2014-04-16 | Cantargia Ab | Novel antibodies and uses thereof |
| GB201413913D0 (en) * | 2014-08-06 | 2014-09-17 | Cantargia Ab | Novel antibodies and uses thereof |
| EA201891084A1 (ru) * | 2015-11-02 | 2019-10-31 | Антитела к il1rap, биспецифические антигенсвязывающие молекулы, которые связываются с il1rap и cd3, и их применение | |
| CN109476737A (zh) | 2015-12-01 | 2019-03-15 | 根马布有限公司 | 抗dr5抗体及其使用方法 |
| CA3084459A1 (en) | 2016-10-16 | 2018-04-19 | Cellerant Therapeutics, Inc. | Anti-il1-rap antibodies |
| WO2018071910A2 (en) | 2016-10-16 | 2018-04-19 | Cellerant Therapeutics, Inc. | Anti-il1-rap antibodies |
| WO2020035577A1 (en) | 2018-08-16 | 2020-02-20 | Cantargia Ab | Anti-il1rap antibody compositions |
| EP4267625A1 (en) | 2020-12-23 | 2023-11-01 | Cantargia AB | Anti-il1rap antibody |
-
2019
- 2019-08-15 WO PCT/EP2019/071974 patent/WO2020035577A1/en not_active Ceased
- 2019-08-15 US US17/267,157 patent/US12209131B2/en active Active
- 2019-08-15 CN CN201980054188.9A patent/CN112638946A/zh active Pending
- 2019-08-15 JP JP2021507831A patent/JP2022532812A/ja active Pending
- 2019-08-15 EP EP19755895.0A patent/EP3837283B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022532812A5 (enExample) | ||
| JP2018507188A5 (enExample) | ||
| JP2020525032A5 (enExample) | ||
| US11352432B2 (en) | Antibodies specifically binding to human IL-1R7 | |
| JP2020501531A5 (enExample) | ||
| JP2019501883A5 (enExample) | ||
| RU2020142965A (ru) | Иммуноглобулин с тандемным расположением fab-фрагментов и его применение | |
| JP2021508469A5 (enExample) | ||
| RU2010149746A (ru) | Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения | |
| JP2018522888A5 (enExample) | ||
| CN101432015A (zh) | 功能性抗体 | |
| WO2009140348A4 (en) | Anti-il-6/il-6r antibodies and methods of use thereof | |
| JP2017530692A5 (enExample) | ||
| RU2019140602A (ru) | АНТИ-GARP-TGF-β-АНТИТЕЛА | |
| JP2018532766A5 (enExample) | ||
| JP2025500971A5 (enExample) | ||
| HK1217958A1 (zh) | 四价双特异性抗体 | |
| JP2017520575A5 (enExample) | ||
| JP2012501670A5 (enExample) | ||
| RU2008152443A (ru) | Антитела высокой аффинности к il-6-рецептору человека | |
| JP2018503380A5 (enExample) | ||
| JP2022512642A5 (enExample) | ||
| JP2023543493A5 (enExample) | ||
| JP2021520201A5 (enExample) | ||
| JP2021521793A5 (enExample) |